| Mrs Brandy Leigh Gallagher, NP | |
|
9850 Genesee Ave Ste 440, La Jolla, CA 92037-1212 | |
| (858) 453-5944 | |
| (858) 429-7925 |
| Full Name | Mrs Brandy Leigh Gallagher |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 9850 Genesee Ave Ste 440, La Jolla, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114476769 | NPI | - | NPPES |
| 193400000X | Other | CA | SINGLE FAMILY NURSE PRACTITIONER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | NP95004515 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Somagen Healthcare Iii Inc | 8921225830 | 39 |
News Archive
The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 2 days ago
| Entity Name | Minuteclinic Diagnostic Medical Group Of San Diego Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568659233 PECOS PAC ID: 2567520414 Enrollment ID: O20090127000249 |
News Archive
The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 2 days ago
| Entity Name | Marque Medical Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538466107 PECOS PAC ID: 9537345665 Enrollment ID: O20110525000301 |
News Archive
The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 2 days ago
| Entity Name | Somagen Healthcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396058137 PECOS PAC ID: 1557530151 Enrollment ID: O20110817000276 |
News Archive
The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 2 days ago
| Entity Name | Somagen Healthcare Ii Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316225147 PECOS PAC ID: 4981877735 Enrollment ID: O20111024000461 |
News Archive
The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 2 days ago
| Entity Name | Somagen Healthcare Iii Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558788620 PECOS PAC ID: 8921225830 Enrollment ID: O20140815001327 |
News Archive
The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Brandy Leigh Gallagher, NP 1241 Hornblend St, San Diego, CA 92109-2947 Ph: (720) 231-4713 | Mrs Brandy Leigh Gallagher, NP 9850 Genesee Ave Ste 440, La Jolla, CA 92037-1212 Ph: (858) 453-5944 |
News Archive
The University of Illinois Hospital & Health Sciences System is the first hospital in the Midwest to offer an improved minimally invasive treatment for atrial fibrillation, also called AF or AFib.
Specific types of "helper" T cells that are crucial to maintaining functioning immune systems contain an enzyme called PDI. This enzyme affects how proteins fold into specific shapes, which in turn influences how the T cells behave.
In a study appearing in the September 27 issue of JAMA, Marc S. Sabatine, M.D., M.P.H., of Brigham and Women's Hospital, Harvard Medical School, Boston, and colleagues evaluated the association between lowering low-density lipoprotein cholesterol (LDL-C) and relative cardiovascular risk reduction across different statin and nonstatin therapies.
Myriad Genetics, Inc. today announced that its Prolaris test has been included in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines) for all men with localized prostate cancer, regardless of their risk category.
HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it has received approval from Health Canada, the country's federal department responsible for helping Canadians maintain their health, to market the HeartWare Ventricular Assist System as a bridge to heart transplantation in patients with end-stage heart failure.
› Verified 2 days ago
Ms. Jumai Fathiya Dawuda, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10710 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-7100 | |
Bonnie Susan Omeara, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9500 Gilman Dr, La Jolla, CA 92093 Phone: 858-534-3300 | |
Yevheniya Khrobust, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, La Jolla, CA 92037 Phone: 858-554-9100 | |
Angela R Acfalle, NP CNS Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9500 Gilman Dr, # 0039, La Jolla, CA 92093 Phone: 858-534-2918 | |
Jessica Merchant, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9834 Genesee Ave Ste 412, La Jolla, CA 92037 Phone: 858-457-8600 | |
Dr. Nicole Lorraine Brustkern, DNP, FNP-C, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5726 La Jolla Blvd, La Jolla, CA 92037 Phone: 425-269-2369 | |
Ms. Deedra Elizabeth Roberts, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5655 Caminito Danzarin, La Jolla, CA 92037 Phone: 512-466-2087 |